Joint publication of UFMG and the National Institute of Cardiology to support the decision of CONITEC, including an indirect comparison study and real-life data on non-treatment.
The Assessment for Disinvestment of Intramuscular Interferon Beta for Relapsing-Remitting Multiple Sclerosis in Brazil – home